Feedback
The current prices are delayed. Login to see live prices.
Krishna Institute of Medical Sciences Ltd.
(KIMS)
10123456789,901234567899012345678970123456789.0012345678900123456789
+44.35 (+2.27%)
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
ā¹1,921.10
Today's high
ā¹1,999
52 week low
ā¹1,457.05
52 week high
ā¹2,356.4
Open
ā¹1,921.15
Prev Close
ā¹1,952.65
Volume (shares)
143,879
Total Trading Value
28.09 Cr
Technicals
SMA
Value
Signal
12-SMA
2,019.57
Bearish
20-SMA
2,015.84
Bearish
50-SMA
2,104.76
Bearish
100-SMA
2,046.39
Bearish
200-SMA
1,982.09
Bearish
Valuations
PE Chart
Median PE (M) : 52.73
Current PE is higher than median PE.
PB Chart
Median PB (M) : 8.22
Current PB is higher than median PB.
Fundamentals
Market Cap
ā¹15,976.00 Cr
Enterprise Value
ā¹16,442.85 Cr
No. of Shares
8 Cr
P/E Ratio(TTM)
47.29
RoE
23.93%
Debt/Equity
0.32
Revenue vs Profitability (In Cr.)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
Margins (%)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Gross Margin
Net Margin
Ratios
Debt/Equity
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Debt to Equity
ROE vs ROCE
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE
Shareholding
Shareholding Pattern
Public : 11.68%
FII : 15.27%
Others : 0%
DII : 34.23%
Promoter : 38.82%
Shareholding History
Sep, 2022Dec, 2022Mar, 2023Jun, 2023Sep, 2023Dec, 2023
Peer Comparison
Peer companies
Market Capital (Cr.)
P/E
P/B
Price(ā¹)
APOLLOHOSP
91,073.2
113.78
12.05
6,303.15
NH
26,105.05
33.21
15.51
1,269.15
ASTERDM
25,969.68
80.91
7.87
522.75
LALPATHLAB
19,411.52
58.12
10.23
2,320.05
KIMS
15,598.22
47.29
8.59
1,951.55
RAINBOW
13,330.72
60.06
10.84
1,320.65
METROPOLIS
8,950.7
70.96
8.78
1,777.6
Discussions
Ā Ā ā¢Ā Ā Apr 3 6:18 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ Global growth investor General Atlantic will acquire a...read more
Ā Ā ā¢Ā Ā Feb 29 11:11 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ GPT Healthcare debuted with a 15% premium over the iss...read more
Ā Ā ā¢Ā Ā Feb 29 3:31 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ GPT Healthcare's IPO debuted with a 16.2% premium, rai...read more
Ā Ā ā¢Ā Ā Feb 28 10:11 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ GPT Healthcare's shares are expected to debut on the e...read more
Ā Ā ā¢Ā Ā Feb 27 2:16 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ The IPO of GPT Healthcare was oversubscribed by 8.5 ti...read more
Ā Ā ā¢Ā Ā Feb 26 7:21 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ The IPO of GPT Healthcare was fully subscribed on the ...read more
Ā Ā ā¢Ā Ā Feb 23 8:06 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ The GPT Healthcare IPO is currently 61% subscribed on ...read more
Ā Ā ā¢Ā Ā Feb 22 7:51 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ GPT Healthcare's IPO is priced at Rs 177-186 per share...read more
Ā Ā ā¢Ā Ā Feb 22 5:03 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ Asit C Mehta has recommended a hold rating on Krishna ...read more
Ā Ā ā¢Ā Ā Feb 20 10:41 PM
š”š²šš š¦ššŗšŗš®šæš
ā¢ GPT Healthcare has fixed a price band of Rs 177-186 pe...read more
Load More Posts
Frequently Asked Questions (FAQs)
How can I take a Paper Trade/Virtual trade in Krishna Institute of Medical Sciences Ltd.?
To place a Paper Trade/Virtual trade on Krishna Institute of Medical Sciences Ltd., you can sign up/login on Frontpage for absolutely free. Then, you can paper trade with real-time prices.
What is the Share Price of Krishna Institute of Medical Sciences Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Krishna Institute of Medical Sciences Ltd. is Rs 1952.65 as of 18 April 2024.
What is the Market Capitalization of Krishna Institute of Medical Sciences Ltd. ?
The current market cap of Krishna Institute of Medical Sciences Ltd. is ā¹15976 Cr. Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Krishna Institute of Medical Sciences Ltd.?
Krishna Institute of Medical Sciences Ltd. has a price-to-earnings (PE) ratio of 47.29 and a price-to-book (PB) ratio of 8.46.
What is the 52-week high/low of Krishna Institute of Medical Sciences Ltd.?
The 52-week high of Krishna Institute of Medical Sciences Ltd. is Rs 2356.4 and the 52-week low is Rs 1457.05
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
Disclaimerā¢Privacyā¢ā¢
FrontPage Ā© 2024